96 results on '"van West D"'
Search Results
2. Demographic, clinical, and service-use characteristics related to the clinician’s recommendation to transition from child to adult mental health services
- Author
-
Gerritsen, S, van Bodegom, L, Dieleman, G, Overbeek, M, Verhulst, F, Wolke, D, Rizopoulos, D, Appleton, R, van Amelsvoort, T, Bodier Rethore, C, Bonnet-Brilhault, F, Charvin, I, Da Fonseca, D, Davidovic, N, Dodig-Curkovic, K, Ferrari, A, Fiori, F, Franic, T, Gatherer, C, de Girolamo, G, Heaney, N, Hendrickx, G, Jardri, R, Kolozsvari, A, Lida-Pulik, H, Lievesley, K, Madan, J, Mastroianni, M, Maurice, V, Mcnicholas, F, Nacinovich, R, Parenti, A, Paul, M, Purper-Ouakil, D, Rivolta, L, de Roeck, V, Russet, F, Saam, M, Sagar-Ouriaghli, I, Santosh, P, Sartor, A, Schulze, U, Scocco, P, Signorini, G, Singh, S, Singh, J, Speranza, M, Stagi, P, Stagni, P, Street, C, Tah, P, Tanase, E, Tremmery, S, Tuffrey, A, Tuomainen, H, Walker, L, Wilson, A, Maras, A, Adams, L, Allibrio, G, Armando, M, Aslan, S, Baccanelli, N, Balaudo, M, Bergamo, F, Bertani, A, Berriman, J, Boon, A, Braamse, K, Breuninger, U, Buttiglione, M, Buttle, S, Schandrin, A, Cammarano, M, Canaway, A, Cantini, F, Cappellari, C, Carenini, M, Carra, G, Ferrari, C, Chianura, K, Coleman, P, Colonna, A, Conese, P, Costanzo, R, Daffern, C, Danckaerts, M, de Giacomo, A, Ermans, J, Farmer, A, Fegert, J, Ferrari, S, Galea, G, Gatta, M, Gheza, E, Goglia, G, Grandetto, M, Griffin, J, Levi, F, Humbertclaude, V, Ingravallo, N, Invernizzi, R, Kelly, C, Killilea, M, Kirwan, J, Klockaerts, C, Kovac, V, Liew, A, Lippens, C, Macchi, F, Manenti, L, Margari, F, Margari, L, Martinelli, P, Mcfadden, L, Menghini, D, Miller, S, Monzani, E, Morini, G, Mutafov, T, O'Hara, L, Negrinotti, C, Nelis, E, Neri, F, Nikolova, P, Nossa, M, Cataldo, M, Noterdaeme, M, Operto, F, Panaro, V, Pastore, A, Pemmaraju, V, Pepermans, A, Petruzzelli, M, Presicci, A, Prigent, C, Rinaldi, F, Riva, E, Roekens, A, Rogers, B, Ronzini, P, Sakar, V, Salvetti, S, Martinelli, O, Sandhu, T, Schepker, R, Siviero, M, Slowik, M, Smyth, C, Conti, P, Spadone, M, Starace, F, Stoppa, P, Tansini, L, Toselli, C, Trabucchi, G, Tubito, M, van Dam, A, van Gutschoven, H, van West, D, Vanni, F, Vannicola, C, Varuzza, C, Varvara, P, Ventura, P, Vicari, S, Vicini, S, von Bentzel, C, Wells, P, Williams, B, Zabarella, M, Zamboni, A, Zanetti, E, Gerritsen S. E., van Bodegom L. S., Dieleman G. C., Overbeek M. M., Verhulst F. C., Wolke D., Rizopoulos D., Appleton R., van Amelsvoort T. A. M. J., Bodier Rethore C., Bonnet-Brilhault F., Charvin I., Da Fonseca D., Davidovic N., Dodig-Curkovic K., Ferrari A., Fiori F., Franic T., Gatherer C., de Girolamo G., Heaney N., Hendrickx G., Jardri R., Kolozsvari A., Lida-Pulik H., Lievesley K., Madan J., Mastroianni M., Maurice V., McNicholas F., Nacinovich R., Parenti A., Paul M., Purper-Ouakil D., Rivolta L., de Roeck V., Russet F., Saam M. C., Sagar-Ouriaghli I., Santosh P. J., Sartor A., Schulze U. M. E., Scocco P., Signorini G., Singh S. P., Singh J., Speranza M., Stagi P., Stagni P., Street C., Tah P., Tanase E., Tremmery S., Tuffrey A., Tuomainen H., Walker L., Wilson A., Maras A., Adams L., Allibrio G., Armando M., Aslan S., Baccanelli N., Balaudo M., Bergamo F., Bertani A., Berriman J., Boon A., Braamse K., Breuninger U., Buttiglione M., Buttle S., Schandrin A., Cammarano M., Canaway A., Cantini F., Cappellari C., Carenini M., Carra G., Ferrari C., Chianura K., Coleman P., Colonna A., Conese P., Costanzo R., Daffern C., Danckaerts M., de Giacomo A., Ermans J. -P., Farmer A., Fegert J. M., Ferrari S., Galea G., Gatta M., Gheza E., Goglia G., Grandetto M. R., Griffin J., Levi F. M., Humbertclaude V., Ingravallo N., Invernizzi R., Kelly C., Killilea M., Kirwan J., Klockaerts C., Kovac V., Liew A., Lippens C., Macchi F., Manenti L., Margari F., Margari L., Martinelli P., McFadden L., Menghini D., Miller S., Monzani E., Morini G., Mutafov T., O'Hara L., Negrinotti C., Nelis E., Neri F., Nikolova P., Nossa M., Cataldo M. G., Noterdaeme M., Operto F., Panaro V., Pastore A., Pemmaraju V., Pepermans A., Petruzzelli M. G., Presicci A., Prigent C., Rinaldi F., Riva E., Roekens A., Rogers B., Ronzini P., Sakar V., Salvetti S., Martinelli O., Sandhu T., Schepker R., Siviero M., Slowik M., Smyth C., Conti P., Spadone M. A., Starace F., Stoppa P., Tansini L., Toselli C., Trabucchi G., Tubito M., van Dam A., van Gutschoven H., van West D., Vanni F., Vannicola C., Varuzza C., Varvara P., Ventura P., Vicari S., Vicini S., von Bentzel C., Wells P., Williams B., Zabarella M., Zamboni A., Zanetti E., Gerritsen, S, van Bodegom, L, Dieleman, G, Overbeek, M, Verhulst, F, Wolke, D, Rizopoulos, D, Appleton, R, van Amelsvoort, T, Bodier Rethore, C, Bonnet-Brilhault, F, Charvin, I, Da Fonseca, D, Davidovic, N, Dodig-Curkovic, K, Ferrari, A, Fiori, F, Franic, T, Gatherer, C, de Girolamo, G, Heaney, N, Hendrickx, G, Jardri, R, Kolozsvari, A, Lida-Pulik, H, Lievesley, K, Madan, J, Mastroianni, M, Maurice, V, Mcnicholas, F, Nacinovich, R, Parenti, A, Paul, M, Purper-Ouakil, D, Rivolta, L, de Roeck, V, Russet, F, Saam, M, Sagar-Ouriaghli, I, Santosh, P, Sartor, A, Schulze, U, Scocco, P, Signorini, G, Singh, S, Singh, J, Speranza, M, Stagi, P, Stagni, P, Street, C, Tah, P, Tanase, E, Tremmery, S, Tuffrey, A, Tuomainen, H, Walker, L, Wilson, A, Maras, A, Adams, L, Allibrio, G, Armando, M, Aslan, S, Baccanelli, N, Balaudo, M, Bergamo, F, Bertani, A, Berriman, J, Boon, A, Braamse, K, Breuninger, U, Buttiglione, M, Buttle, S, Schandrin, A, Cammarano, M, Canaway, A, Cantini, F, Cappellari, C, Carenini, M, Carra, G, Ferrari, C, Chianura, K, Coleman, P, Colonna, A, Conese, P, Costanzo, R, Daffern, C, Danckaerts, M, de Giacomo, A, Ermans, J, Farmer, A, Fegert, J, Ferrari, S, Galea, G, Gatta, M, Gheza, E, Goglia, G, Grandetto, M, Griffin, J, Levi, F, Humbertclaude, V, Ingravallo, N, Invernizzi, R, Kelly, C, Killilea, M, Kirwan, J, Klockaerts, C, Kovac, V, Liew, A, Lippens, C, Macchi, F, Manenti, L, Margari, F, Margari, L, Martinelli, P, Mcfadden, L, Menghini, D, Miller, S, Monzani, E, Morini, G, Mutafov, T, O'Hara, L, Negrinotti, C, Nelis, E, Neri, F, Nikolova, P, Nossa, M, Cataldo, M, Noterdaeme, M, Operto, F, Panaro, V, Pastore, A, Pemmaraju, V, Pepermans, A, Petruzzelli, M, Presicci, A, Prigent, C, Rinaldi, F, Riva, E, Roekens, A, Rogers, B, Ronzini, P, Sakar, V, Salvetti, S, Martinelli, O, Sandhu, T, Schepker, R, Siviero, M, Slowik, M, Smyth, C, Conti, P, Spadone, M, Starace, F, Stoppa, P, Tansini, L, Toselli, C, Trabucchi, G, Tubito, M, van Dam, A, van Gutschoven, H, van West, D, Vanni, F, Vannicola, C, Varuzza, C, Varvara, P, Ventura, P, Vicari, S, Vicini, S, von Bentzel, C, Wells, P, Williams, B, Zabarella, M, Zamboni, A, Zanetti, E, Gerritsen S. E., van Bodegom L. S., Dieleman G. C., Overbeek M. M., Verhulst F. C., Wolke D., Rizopoulos D., Appleton R., van Amelsvoort T. A. M. J., Bodier Rethore C., Bonnet-Brilhault F., Charvin I., Da Fonseca D., Davidovic N., Dodig-Curkovic K., Ferrari A., Fiori F., Franic T., Gatherer C., de Girolamo G., Heaney N., Hendrickx G., Jardri R., Kolozsvari A., Lida-Pulik H., Lievesley K., Madan J., Mastroianni M., Maurice V., McNicholas F., Nacinovich R., Parenti A., Paul M., Purper-Ouakil D., Rivolta L., de Roeck V., Russet F., Saam M. C., Sagar-Ouriaghli I., Santosh P. J., Sartor A., Schulze U. M. E., Scocco P., Signorini G., Singh S. P., Singh J., Speranza M., Stagi P., Stagni P., Street C., Tah P., Tanase E., Tremmery S., Tuffrey A., Tuomainen H., Walker L., Wilson A., Maras A., Adams L., Allibrio G., Armando M., Aslan S., Baccanelli N., Balaudo M., Bergamo F., Bertani A., Berriman J., Boon A., Braamse K., Breuninger U., Buttiglione M., Buttle S., Schandrin A., Cammarano M., Canaway A., Cantini F., Cappellari C., Carenini M., Carra G., Ferrari C., Chianura K., Coleman P., Colonna A., Conese P., Costanzo R., Daffern C., Danckaerts M., de Giacomo A., Ermans J. -P., Farmer A., Fegert J. M., Ferrari S., Galea G., Gatta M., Gheza E., Goglia G., Grandetto M. R., Griffin J., Levi F. M., Humbertclaude V., Ingravallo N., Invernizzi R., Kelly C., Killilea M., Kirwan J., Klockaerts C., Kovac V., Liew A., Lippens C., Macchi F., Manenti L., Margari F., Margari L., Martinelli P., McFadden L., Menghini D., Miller S., Monzani E., Morini G., Mutafov T., O'Hara L., Negrinotti C., Nelis E., Neri F., Nikolova P., Nossa M., Cataldo M. G., Noterdaeme M., Operto F., Panaro V., Pastore A., Pemmaraju V., Pepermans A., Petruzzelli M. G., Presicci A., Prigent C., Rinaldi F., Riva E., Roekens A., Rogers B., Ronzini P., Sakar V., Salvetti S., Martinelli O., Sandhu T., Schepker R., Siviero M., Slowik M., Smyth C., Conti P., Spadone M. A., Starace F., Stoppa P., Tansini L., Toselli C., Trabucchi G., Tubito M., van Dam A., van Gutschoven H., van West D., Vanni F., Vannicola C., Varuzza C., Varvara P., Ventura P., Vicari S., Vicini S., von Bentzel C., Wells P., Williams B., Zabarella M., Zamboni A., and Zanetti E.
- Abstract
Purpose: The service configuration with distinct child and adolescent mental health services (CAMHS) and adult mental health services (AMHS) may be a barrier to continuity of care. Because of a lack of transition policy, CAMHS clinicians have to decide whether and when a young person should transition to AMHS. This study describes which characteristics are associated with the clinicians’ advice to continue treatment at AMHS. Methods: Demographic, family, clinical, treatment, and service-use characteristics of the MILESTONE cohort of 763 young people from 39 CAMHS in Europe were assessed using multi-informant and standardized assessment tools. Logistic mixed models were fitted to assess the relationship between these characteristics and clinicians’ transition recommendations. Results: Young people with higher clinician-rated severity of psychopathology scores, with self- and parent-reported need for ongoing treatment, with lower everyday functional skills and without self-reported psychotic experiences were more likely to be recommended to continue treatment. Among those who had been recommended to continue treatment, young people who used psychotropic medication, who had been in CAMHS for more than a year, and for whom appropriate AMHS were available were more likely to be recommended to continue treatment at AMHS. Young people whose parents indicated a need for ongoing treatment were more likely to be recommended to stay in CAMHS. Conclusion: Although the decision regarding continuity of treatment was mostly determined by a small set of clinical characteristics, the recommendation to continue treatment at AMHS was mostly affected by service-use related characteristics, such as the availability of appropriate services.
- Published
- 2022
3. Can psychiatric childhood disorders be due to inborn errors of metabolism?
- Author
-
Simons, A., Eyskens, F., Glazemakers, I., and van West, D.
- Published
- 2017
- Full Text
- View/download PDF
4. Correction to: ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services (European Child & Adolescent Psychiatry, (2021), 10.1007/s00787-020-01699-x)
- Author
-
Revet, A. Hebebrand, J. Anagnostopoulos, D. Kehoe, L.A. Banaschewski, T. Bender, S. Csábi, G. Çuhadaroğlu, F. Dashi, E. Delorme, R. Radobuljac, M.D. Eliez, S. Krantz, M.F. Fricke, O. Gerstenberg, M. Giannopoulou, I. Graell, M. Kumperscak, H.G. Herpertz-Dahlmann, B. Huscsava, M. Kaess, M. Kapornai, K. Karwautz, A. Kresakova, D. Kölch, M. Kotsis, K. Lazaro, L. Moehler, E. Morón-Nozaleda, M.G. Özyurt, G. Pászthy, B. Podlipny, J. Purper-Ouakil, D. Remberk, B. Serdari, A. Stene, L.E. Thun-Hohenstein, L. Trebaticka, J. van West, D. Vitiello, B. Young, H. Yurteri, N. Zepf, F.D. Zielinska-Wieniawska, A. Zuddas, A. Klauser, P. COVID-19 Child Adolescent Psychiatry Consortium
- Subjects
humanities - Abstract
In the original articles, the last four members’ of COVID-19 Child and Adolescent Psychiatry Consortium affiliation were incorrectly published. The correct affiliation are given below. Nihal Yurteri: Department of Child and Adolescent Psychiatry, Faculty of Medicine, Düzce University, Düzce, Turkey Florian Daniel Zepf: Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany Anna Zielinska-Wieniawska: Department of Child and Adolescent Psychiatry, Medical University of Warsaw, Warsaw, Poland Alessandro Zuddas: Department of Biomedical Science and “G. Brotzu” Hospital Trust, Child and Adolescent Neuropsychiatry, University of Cagliari, Cagliari, Italy The original article has been corrected. © 2021, Springer-Verlag GmbH Germany, part of Springer Nature.
- Published
- 2021
5. [What are possible applications of virtual reality for forensic psychiatry?]
- Author
-
Roggeman, S, Van Wallendael, KLP, Van West, D, and Jeandarme, I
- Abstract
BACKGROUND: Virtual reality (VR) has been on the rise in recent years due to the better quality and accessibility of VR glasses and software. Despite the fact that VR is being used more often in psychiatric care, little is known about the possible applications of VR in forensic psychiatry. AIM: To investigate which possible VR-applications already exist that can also be used in forensic psychiatry and what the possible risks are. METHOD: Scientific literature was consulted in PubMed, Web of Knowledge, Embase en Cochrane Library to search for immersive VR-applications for aggression, motivation and the most prevalent psychopathologies in forensic psychiatry. RESULTS: Several relevant VR-applications were found that can be used in the diagnosis or treatment of forensic psychiatric patients. Despite the limited number of empirical studies, several authors emphasize the potential benefits of VR for this target group. CONCLUSION: Due to the low number of studies of good quality on the use of VR in psychiatric care, it is currently not yet possible to draw clear conclusions about efficiency, deployability and specific applications. However, there is enough potential within forensic psychiatry to integrate VR into various parts of the care process, such as treatment, diagnosis and risk assessment. ispartof: Tijdschr Psychiatr vol:63 issue:11 pages:810-815 ispartof: location:Netherlands status: published
- Published
- 2021
6. A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression
- Author
-
van West, D, Del-Favero, J, Aulchenko, Y, Oswald, P, Souery, D, Forsgren, T, Sluijs, S, Bel-Kacem, S, Adolfsson, R, Mendlewicz, J, Van Duijn, C, Deboutte, D, Van Broeckhoven, C, and Claes, S
- Published
- 2004
- Full Text
- View/download PDF
7. Lowered Serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa
- Author
-
van West, D., Monteleone, P., Di Lieto, A., De Meester, I., Durinx, C., Scharpe, S., Lin, A., Maj, M., and Maes, M.
- Published
- 2000
- Full Text
- View/download PDF
8. Gedragsstoornissen bij meisjes : een overzicht van risicofactoren en ontwikkelingsverloop
- Author
-
Merckx, W, Van West, D, and Klinische en Levenslooppsychologie
- Subjects
Human medicine - Abstract
achtergrond Studies over gedragsstoornissen bij meisjes zijn relatief zeldzaam. Voor een optimale preventie en behandeling is een degelijke kennis van de risicofactoren en het ontwikkelingsverloop echter erg belangrijk. doelEen overzicht creëren van wat er bekend is over risicofactoren voor en ontwikkelingsverloop van gedragsstoornissen bij meisjes. methodeBinnen de databanken eric, PubMed en Medline werd gezocht naar artikelen met het passende onderwerp. We namen 41 studies door en vatten de belangrijkste resultaten samen. resultatenMeerdere risicofactoren kunnen bijdragen tot de ontwikkeling van gedragsstoornissen bij meisjes. Net zoals jongens kunnen ook meisjes de life-course-persistent vorm van antisociaal gedrag vertonen. Bij meisjes met deze vorm zag men vaak ernstige risicofactoren. Meisjes met ernstige vormen van antisociaal gedrag hebben een verhoogd risico op aanpassingsproblemen op latere leeftijd. conclusieOm aan gerichte preventie en behandeling te kunnen doen, dient men ook in toekomstig onderzoek voldoende aandacht aan dit onderwerp te besteden.
- Published
- 2016
9. Kinder- en jeugdpsychiatrie : inspirerend en dynamisch
- Author
-
Reichart, C G, Roza, S, van Amelsvoort, T A M J, Van West, D, and Klinische en Levenslooppsychologie
- Subjects
Human medicine - Published
- 2015
10. Vroeg ontstane eetstoornissen : literatuuroverzicht
- Author
-
Poppe, I, Simons, A, Glazemakers, I, Van West, D, Wiskunde, Operationeel Onderzoek, Statistiek en Informatica voor Management, and Klinische en Levenslooppsychologie
- Subjects
Adolescent ,Humans ,risk factors ,Human medicine ,Age of Onset ,Child ,anorexia nervosa ,Netherlands - Abstract
BACKGROUND: The incidence of anorexia nervosa (AN) in adolescents has increased significantly in recent years. In several studies and in the media it has been suggested that AN has recently become more prevalent in the pre-adolescence. In view of the impact that an eating disorder can have on a child, it is important to diagnose and start treating the illness as early as possible. AIM: To review the literature on the characteristics and susceptibilities of patients with eating disorders because this information can be important for early diagnosis, prevention and identification of susceptibilities to early-onset eating disorders. METHOD: We searched the literature for articles relating to early-onset eating disorders. We based our search on PubMed and on related relevant articles listed in the references. We selected 34 relevant articles published between 1987 and 2014. RESULTS: The literature lists characteristics and susceptibilities at various levels. Many types of factors are involved; examples of 'biological' factors are prior streptococcal infection, previous consultations with GP and a patients medical history; psychological factors include comorbidity, temperament, a particular personality profile, maturation-anxiety; environmental factors such as family history, family functioning and/or stressful events can play a role in the development of eating disorders. CONCLUSION The literature indicates that the early development of AN in children is related to a complex combination of etiological factors. However, there is a need for more research into this group of patients.
- Published
- 2015
11. Activering van het inflammatiesysteem: een andere kijk op de etiologie van depressie
- Author
-
null VAN WEST D and null MAES M
- Subjects
General Medicine - Published
- 2000
- Full Text
- View/download PDF
12. Can psychiatric childhood disorders be due to inborn errors of metabolism?
- Author
-
Simons, A., primary, Eyskens, F., additional, Glazemakers, I., additional, and van West, D., additional
- Published
- 2016
- Full Text
- View/download PDF
13. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
- Author
-
Price, D, van West, D, Brusselle, Guy, Gruffydd-Jones, K, Jones, R, Miravitlles, M, de Rossi, A, Hutton, C, Ashton, VL, Stewart, R, Bichel, K, Price, D, van West, D, Brusselle, Guy, Gruffydd-Jones, K, Jones, R, Miravitlles, M, de Rossi, A, Hutton, C, Ashton, VL, Stewart, R, and Bichel, K
- Abstract
Background: Despite the availability of national and international guidelines, evidence suggests that chronic obstructive pulmonary disease (COPD) treatment is not always prescribed according to recommendations. This study evaluated the current management of patients with COPD using a large UK primary-care database. Methods: This analysis used electronic patient records and patient-completed questionnaires from the Optimum Patient Care Research Database. Data on current management were analyzed by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) group and presence or absence of a concomitant asthma diagnosis, in patients with a COPD diagnosis at >= 35 years of age and with spirometry results supportive of the COPD diagnosis. Results: A total of 24,957 patients were analyzed, of whom 13,557 (54.3%) had moderate airflow limitation (GOLD Stage 2 COPD). The proportion of patients not receiving pharmacologic treatment for COPD was 17.0% in the total COPD population and 17.7% in the GOLD Stage 2 subset. Approximately 50% of patients in both cohorts were receiving inhaled corticosteroids (ICS), either in combination with a long-acting beta(2)-agonist (LABA; 26.7% for both cohorts) or a LABA and a long-acting muscarinic antagonist (LAMA; 23.2% and 19.9%, respectively). ICS + LABA and ICS + LABA + LAMA were the most frequently used treatments in GOLD Groups A and B. Of patients without concomitant asthma, 53.7% of the total COPD population and 50.2% of the GOLD Stage 2 subset were receiving ICS. Of patients with GOLD Stage 2 COPD and no exacerbations in the previous year, 49% were prescribed ICS. A high proportion of GOLD Stage 2 COPD patients were symptomatic on their current management (36.6% with modified Medical Research Council score >= 2; 76.4% with COPD Assessment Test score >= 10). Conclusion: COPD is not treated according to GOLD and National Institute for Health and Care Excellence recommendations in the UK primary-care setting. Some patients recei
- Published
- 2014
14. Activation of the inflammatory response system
- Author
-
van West D, Michael Maes, and Clinical and Lifespan Psychology
- Abstract
Major depression is accompanied by various direct and indirect indicators of a moderate activation of the inflammatory response system (IRS). Increased production of proinflammatory cytokines, such as interleukin-1 (IL-1), IL-6 and interferon (IFNgamma), may play a crucial role in the immune and acute phase response in depression. Lower serum zinc and changes in the erythron are indirect indicators of IRS activation in depression. The reciprocal relationships between IRS activation and hypothalamic-pituitary-adrenal (HPA)-axis hyperactivity, alterations in HP thyroid (HPT)-axis function and the availability of tryptophan to the brain led us to hypothesize that these neuroendocrine changes in depression are indicators of IRS activation and that a combined dysregulation of the IRS, the turnover of serotonin (5-HT) and the HPA-axis is an integral component of depression. The IRS activation model of depression provides an explanation for the psycho-social (external stress) as well as organic (internal stress) etiology of major depression. Antidepressive treatments with various antidepressive agents, including SSRIs, tricyclic and heterocyclic antidepressants, have in vivo and in vitro negative immunoregulatory effects, suggesting that their antidepressant efficacy may be attributed, in part, to their immune effects.
- Published
- 1999
15. P.1.a.004 Associations between AVPR1b and NR3C1 gene variants and HPA axis responses to psychosocial stress
- Author
-
van West, D., primary, Del-Favero, J., additional, Deboutte, D., additional, Van Broeckhoven, C., additional, and Claes, S., additional
- Published
- 2010
- Full Text
- View/download PDF
16. P.7.b.005 Arginine vasopressin receptor gene-based single nucleotide polymorphism (SNP) analysis in ADHD
- Author
-
van West, D., primary, Del-Favero, J., additional, Deboutte, D., additional, Van Broeckhoven, C., additional, and Claes, S., additional
- Published
- 2009
- Full Text
- View/download PDF
17. Stress Responsivity in Childhood and Adulthood: Role of the Glucocorticoid Receptor Gene
- Author
-
Claes, S., primary, van West, D., additional, Del-Favero, J., additional, and Deboutte, D., additional
- Published
- 2009
- Full Text
- View/download PDF
18. Genetic variation in stress response: The role of the arginine vasopressin 1b receptor and the glucocorticoid receptor genes
- Author
-
van West, D., primary, Deboutte, D., additional, and Claes, S., additional
- Published
- 2008
- Full Text
- View/download PDF
19. HPA axis dysfunction in psychiatry: Genetic background
- Author
-
Claes, S.J., primary, Van Den Eede, F., additional, van West, D., additional, Del-Favero, J., additional, and Van Broeckhoven, C., additional
- Published
- 2007
- Full Text
- View/download PDF
20. P.1.020 A whole gene based SNP study of the AVP 1B receptor gene: A possible protective effect in the etiology of major depression
- Author
-
Van West, D., primary, Del Favero, J., additional, Aulchenko, Y., additional, Souery, D., additional, Mendlewicz, J., additional, Adolfsson, R., additional, Deboutte, D., additional, Van Duijn, C., additional, Van Broeckhoven, C., additional, and Claes, S., additional
- Published
- 2003
- Full Text
- View/download PDF
21. P.3.001 Increased hypothalamic-pituitary adrenal axis activity in children with anxiety disorders and matched controls
- Author
-
Van West, D., primary, Claes, S., additional, Sulon, J., additional, and Deboutte, D., additional
- Published
- 2003
- Full Text
- View/download PDF
22. P.6.003 Reduced hypothalamic-pituitary adrenal axis activity in children with attention deficit hyperactivity disorder and matched controls
- Author
-
Van West, D., primary, Claes, S., additional, Sulon, J., additional, and Deboutte, D., additional
- Published
- 2003
- Full Text
- View/download PDF
23. Cytokines in de obsessief compulsieve stoornis en in anorexia nervosa: een overzicht
- Author
-
van West, D., primary and Maes, M., additional
- Published
- 1999
- Full Text
- View/download PDF
24. Effects of atypical antipsychotics on the inflammatory response system In schizophrenic patients resistant to treatment with haloperidol
- Author
-
Maes, M., primary, Chiavetto, L.Bocchio, additional, Bignotti, S., additional, Tura, G.B., additional, Boin, F., additional, Racagni, G., additional, Van West, D., additional, Kenis, G., additional, Bosmans, E., additional, and Altamura, C.A., additional
- Published
- 1999
- Full Text
- View/download PDF
25. Differences in hypothalamic-pituitary-adrenal axis functioning among children with ADHD predominantly inattentive and combined types.
- Author
-
van West D, Claes S, and Deboutte D
- Abstract
Some evidence suggests that the HPA axis may be dysfunctional in children with attention-deficit/hyperactivity disorder (ADHD). The aim of this study was to investigate whether a different pattern of HPA axis activity is found between the inattentive (I) and combined (C) subtypes of ADHD, in comparison with healthy control children. A total of 100 prepubertal subjects [52 children with ADHD combined type (ADHD-C), 23 children with ADHD predominantly inattentive type (ADHD-I), and 25 healthy control subjects] were studied. The effects of stress were studied by comparing cortisol responses to a psychosocial stressor, consisting of a public speaking task. Children with ADHD-I showed an elevated cortisol response to the psychosocial stressor, in contrast to children with ADHD-C who showed a blunted cortisol response to the psychosocial stressor. When a distinction was made between responders and non-responders (a subject was classified as a responder when there was an increase in cortisol reactivity), hyperactivity symptoms were clearly related to a lower cortisol reactivity to stress. The results indicate that a low-cortisol responsivity to stress may be a neurobiological marker for children with ADHD-C, but not for those with ADHD-I. Directions for future research and clinical implications are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
26. Neuroendocrine and Immune Aspects of Fibromyalgia.
- Author
-
van West, D. and Maes, M.
- Subjects
- *
FIBROMYALGIA , *TRYPTOPHAN , *ENDOPEPTIDASES - Abstract
Fibromyalgia is a form of non-articular rheumatism characterised by long term (>3 months) and widespread musculoskeletal aching, stiffness and pressure hyperalgesia at characteristic soft tissue sites, called soft tissue tender points. The biophysiology of fibromyalgia, however, has remained elusive and the treatment remains mainly empirical. This article reviews the neuroendocrine-immune pathophysiology of fibromyalgia. There is no major evidence that fibromyalgia is accompanied by activation of the inflammatory response system, by immune activation or by an inflammatory process. There is some evidence that fibromyalgia is accompanied by some signs of immunosuppression, suggesting that immunomodifying drugs could have potential in the treatment of fibromyalgia. Recent trials with cytokines, such as interferon-α, have been undertaken in patients with fibromyalgia. Immunotherapy with these agents, however, may induce symptoms reminiscent of fibromyalgia and depression in a considerable number of patients. Lowered serum activity of prolyl endopeptidase (PEP), a cytosolic endopeptidase that cleaves peptide bonds on the carboxyl side of proline in proteins of relatively small molecular mass, may play a role in the biophysiology of fibromyalgia through diminished inactivation of algesic and depression-related peptides, e.g. substance P. Trials with PEP agonists could be worthwhile in fibromyalgia. The muscle energy depletion hypothesis of fibromyalgia is supported by findings that this condition is accompanied by lowered plasma levels of branched chain amino acids (BCAAs), i.e. valine, leucine and isoleucine. Since there is evidence that BCAA supplementation decreases muscle catabolism and has ergogenic values, a supplemental trial with BCAAs in fibromyalgia appears to be justified. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
27. S63-04 Stress responsivity in childhood and adulthood: Role of the glucocorticoid receptor gene
- Author
-
Claes, S., van West, D., Del-Favero, J., and Deboutte, D.
- Published
- 2009
- Full Text
- View/download PDF
28. Research projects in the collaborative antwerp psychiatric research institute
- Author
-
Sabbe B, Dom G, Glazemakers I, Goethals K, Janssens A, Morrens M, Schrijvers D, Van Den Eede F, Jan Van Hecke, Deboutte D, and Van West D
29. Demographic, clinical, and service-use characteristics related to the clinician’s recommendation to transition from child to adult mental health services
- Author
-
Gerritsen, S. E., van Bodegom, L. S., Dieleman, G. C., Overbeek, M. M., Verhulst, F. C., Wolke, Dieter, Rizopoulos, D., Appleton, R., van Amelsvoort, T. A. M. J., Bodier Rethore, C., Bonnet-Brilhault, F., Charvin, I., Da Fonseca, D., Davidović, N., Dodig-Ćurković, K., Ferrari, A., Fiori, F., Franić, T., Gatherer, C., de Girolamo, G., Heaney, N., Hendrickx, G., Jardri, R., Kolozsvari, A., Lida-Pulik, H., Lievesley, K., Madan, J., Mastroianni, M., Maurice, V., McNicholas, F., Nacinovich, R., Parenti, A., Paul, M., Purper-Ouakil, D., Rivolta, L., de Roeck, V., Russet, F., Saam, M. C., Sagar-Ouriaghli, I., Santosh, P. J., Sartor, A., Schulze, U. M. E., Scocco, P., Signorini, G., Singh, S. P., Singh, J., Speranza, M., Stagi, P., Stagni, P., Street, C., Tah, P., Tanase, E., Tremmery, S., Tuffrey, A., Tuomainen, H., Walker, L., Wilson, A., Maras, A., Adams, Laura, Allibrio, Giovanni, Armando, Marco, Aslan, Sonja, Baccanelli, Nadia, Balaudo, Monica, Bergamo, Fabia, Bertani, Angelo, Berriman, Jo, Boon, Albert, Braamse, Karen, Breuninger, Ulrike, Buttiglione, Maura, Buttle, Sarah, Schandrin, Aurélie, Cammarano, Marco, Canaway, Alastair, Cantini, Fortunata, Cappellari, Cristiano, Carenini, Marta, Carrà, Giuseppe, Ferrari, Cecilia, Chianura, Krizia, Coleman, Philippa, Colonna, Annalisa, Conese, Patrizia, Costanzo, Raffaella, Daffern, Claire, Danckaerts, Marina, de Giacomo, Andrea, Ermans, Jean-Pierre, Farmer, Alan, Fegert, Jörg M., Ferrari, Sabrina, Galea, Giuliana, Gatta, Michela, Gheza, Elisa, Goglia, Giacomo, Grandetto, MariaRosa, Griffin, James, Levi, Flavia Micol, Humbertclaude, Véronique, Ingravallo, Nicola, Invernizzi, Roberta, Kelly, Caoimhe, Killilea, Meghan, Kirwan, James, Klockaerts, Catherine, Kovač, Vlatka, Liew, Ashley, Lippens, Christel, Macchi, Francesca, Manenti, Lidia, Margari, Francesco, Margari, Lucia, Martinelli, Paola, McFadden, Leighton, Menghini, Deny, Miller, Sarah, Monzani, Emiliano, Morini, Giorgia, Mutafov, Todor, O’Hara, Lesley, Negrinotti, Cristina, Nelis, Emmanuel, Neri, Francesca, Nikolova, Paulina, Nossa, Marzia, Cataldo, Maria Giulia, Noterdaeme, Michele, Operto, Francesca, Panaro, Vittoria, Pastore, Adriana, Pemmaraju, Vinuthna, Pepermans, Ann, Petruzzelli, Maria Giuseppina, Presicci, Anna, Prigent, Catherine, Rinaldi, Francesco, Riva, Erika, Roekens, Anne, Rogers, Ben, Ronzini, Pablo, Sakar, Vehbi, Salvetti, Selena, Martinelli, Ottaviano, Sandhu, Tanveer, Schepker, Renate, Siviero, Marco, Slowik, Michael, Smyth, Courtney, Conti, Patrizia, Spadone, Maria Antonietta, Starace, Fabrizio, Stoppa, Patrizia, Tansini, Lucia, Toselli, Cecilia, Trabucchi, Guido, Tubito, Maria, van Dam, Arno, van Gutschoven, Hanne, van West, Dirk, Vanni, Fabio, Vannicola, Chiara, Varuzza, Cristiana, Varvara, Pamela, Ventura, Patrizia, Vicari, Stefano, Vicini, Stefania, von Bentzel, Carolin, Wells, Philip, Williams, Beata, Zabarella, Marina, Zamboni, Anna, Zanetti, Edda, HASH(0x5651c9679ff8), RS: MHeNs - R2 - Mental Health, Psychiatrie & Neuropsychologie, MUMC+: MA Med Staf Spec Psychiatrie (9), Child and Adolescent Psychiatry / Psychology, Epidemiology, Clinical Child and Family Studies, LEARN! - Child rearing, APH - Mental Health, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier de Versailles André Mignot (CHV), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), CHU Lille, Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, The MILESTONE project was funded by EU FP7 programme under grant number 602442. SPS is part-funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands (NIHR CLAHRC WM), now recommissioned as NIHR Applied Research Collaboration West Midlands. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. PS is the co-inventor of the HealthTrackerTM and is the Chief Executive Officer and shareholder in HealthTracker Ltd. FF is a Chief Technical Officer and AK is the Chief Finance Officer employed by HealthTracker Ltd, respectively. FCV publishes the Dutch translations of ASEBA, from which he receives remuneration. AM was a speaker and advisor for Neurim, Shire, Infectopharm, and Lilly (all not related to transition research)., European Project: 602442,EC:FP7:HEALTH,FP7-HEALTH-2013-INNOVATION-1,MILESTONE(2014), The Milestone Consortium, Gerritsen, S, van Bodegom, L, Dieleman, G, Overbeek, M, Verhulst, F, Wolke, D, Rizopoulos, D, Appleton, R, van Amelsvoort, T, Bodier Rethore, C, Bonnet-Brilhault, F, Charvin, I, Da Fonseca, D, Davidovic, N, Dodig-Curkovic, K, Ferrari, A, Fiori, F, Franic, T, Gatherer, C, de Girolamo, G, Heaney, N, Hendrickx, G, Jardri, R, Kolozsvari, A, Lida-Pulik, H, Lievesley, K, Madan, J, Mastroianni, M, Maurice, V, Mcnicholas, F, Nacinovich, R, Parenti, A, Paul, M, Purper-Ouakil, D, Rivolta, L, de Roeck, V, Russet, F, Saam, M, Sagar-Ouriaghli, I, Santosh, P, Sartor, A, Schulze, U, Scocco, P, Signorini, G, Singh, S, Singh, J, Speranza, M, Stagi, P, Stagni, P, Street, C, Tah, P, Tanase, E, Tremmery, S, Tuffrey, A, Tuomainen, H, Walker, L, Wilson, A, Maras, A, Adams, L, Allibrio, G, Armando, M, Aslan, S, Baccanelli, N, Balaudo, M, Bergamo, F, Bertani, A, Berriman, J, Boon, A, Braamse, K, Breuninger, U, Buttiglione, M, Buttle, S, Schandrin, A, Cammarano, M, Canaway, A, Cantini, F, Cappellari, C, Carenini, M, Carra, G, Ferrari, C, Chianura, K, Coleman, P, Colonna, A, Conese, P, Costanzo, R, Daffern, C, Danckaerts, M, de Giacomo, A, Ermans, J, Farmer, A, Fegert, J, Ferrari, S, Galea, G, Gatta, M, Gheza, E, Goglia, G, Grandetto, M, Griffin, J, Levi, F, Humbertclaude, V, Ingravallo, N, Invernizzi, R, Kelly, C, Killilea, M, Kirwan, J, Klockaerts, C, Kovac, V, Liew, A, Lippens, C, Macchi, F, Manenti, L, Margari, F, Margari, L, Martinelli, P, Mcfadden, L, Menghini, D, Miller, S, Monzani, E, Morini, G, Mutafov, T, O'Hara, L, Negrinotti, C, Nelis, E, Neri, F, Nikolova, P, Nossa, M, Cataldo, M, Noterdaeme, M, Operto, F, Panaro, V, Pastore, A, Pemmaraju, V, Pepermans, A, Petruzzelli, M, Presicci, A, Prigent, C, Rinaldi, F, Riva, E, Roekens, A, Rogers, B, Ronzini, P, Sakar, V, Salvetti, S, Martinelli, O, Sandhu, T, Schepker, R, Siviero, M, Slowik, M, Smyth, C, Conti, P, Spadone, M, Starace, F, Stoppa, P, Tansini, L, Toselli, C, Trabucchi, G, Tubito, M, van Dam, A, van Gutschoven, H, van West, D, Vanni, F, Vannicola, C, Varuzza, C, Varvara, P, Ventura, P, Vicari, S, Vicini, S, von Bentzel, C, Wells, P, Williams, B, Zabarella, M, Zamboni, A, and Zanetti, E
- Subjects
Adult mental health service ,Adult ,Mental Health Services ,Parents ,Health (social science) ,Child and adolescent mental health service ,Social Psychology ,RJ ,Epidemiology ,ADOLESCENT ,Child and adolescent mental health services ,Adult mental health services ,Young adults ,Transition ,SDG 3 - Good Health and Well-being ,PEOPLE ,SCHIZOPHRENIA ,Humans ,Family ,Child ,Demography ,Mental Disorders ,CARE ,Psychiatry and Mental health ,Young adult ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,RA - Abstract
Purpose The service configuration with distinct child and adolescent mental health services (CAMHS) and adult mental health services (AMHS) may be a barrier to continuity of care. Because of a lack of transition policy, CAMHS clinicians have to decide whether and when a young person should transition to AMHS. This study describes which characteristics are associated with the clinicians’ advice to continue treatment at AMHS. Methods Demographic, family, clinical, treatment, and service-use characteristics of the MILESTONE cohort of 763 young people from 39 CAMHS in Europe were assessed using multi-informant and standardized assessment tools. Logistic mixed models were fitted to assess the relationship between these characteristics and clinicians’ transition recommendations. Results Young people with higher clinician-rated severity of psychopathology scores, with self- and parent-reported need for ongoing treatment, with lower everyday functional skills and without self-reported psychotic experiences were more likely to be recommended to continue treatment. Among those who had been recommended to continue treatment, young people who used psychotropic medication, who had been in CAMHS for more than a year, and for whom appropriate AMHS were available were more likely to be recommended to continue treatment at AMHS. Young people whose parents indicated a need for ongoing treatment were more likely to be recommended to stay in CAMHS. Conclusion Although the decision regarding continuity of treatment was mostly determined by a small set of clinical characteristics, the recommendation to continue treatment at AMHS was mostly affected by service-use related characteristics, such as the availability of appropriate services.
- Published
- 2022
- Full Text
- View/download PDF
30. ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services
- Author
-
Revet, Alexis, Hebebrand, Johannes, Anagnostopoulos, Dimitris, Kehoe, Laura A., Banaschewski, Tobias, Bender, Stephan, Csábi, Györgyi, Çuhadaroğlu, Füsun, Dashi, Elona, Delorme, Richard, Radobuljac, Maja Drobnic, Eliez, Stephan, Krantz, Mette Falkenberg, Fricke, Oliver, Gerstenberg, Miriam, Giannopoulou, Ioanna, Graell, Montserrat, Kumperscak, Hojka Gregoric, Herpertz-Dahlmann, Beate, Huscsava, Mercedes, Kaess, Michael, Kapornai, Krisztina, Karwautz, Andreas, Kresakova, Dominika, Kölch, Michael, Kotsis, Konstantinos, Lazaro, Luisa, Moehler, Eva, Morón-Nozaleda, M. Goretti, Özyurt, Gonca, Pászthy, Bea, Podlipny, Jiri, Purper-Ouakil, Diane, Remberk, Barbara, Serdari, Aspasia, Stene, Lise Eilin, Thun-Hohenstein, Leonhard, Trebaticka, Jana, van West, Dirk, Vitiello, Benedetto, Young, Héloïse, Yurteri, Nihal, Zepf, Florian Daniel, Zielinska-Wieniawska, Anna, Zuddas, Alessandro, Klauser, Paul, COVID-19 Child and Adolescent Psychiatry Consortium, Banaschewski, T., Bender, S., Csábi, G., Çuhadaroğlu, F., Dashi, E., Delorme, R., Radobuljac, M.D., Eliez, S., Krantz, M.F., Fricke, O., Gerstenberg, M., Giannopoulou, I., Graell, M., Kumperscak, H.G., Herpertz-Dahlmann, B., Huscsava, M., Kaess, M., Kapornai, K., Karwautz, A., Kresakova, D., Kölch, M., Kotsis, K., Lazaro, L., Moehler, E., Morón-Nozaleda, M.G., Özyurt, G., Pászthy, B., Podlipny, J., Purper-Ouakil, D., Remberk, B., Serdari, A., Stene, L.E., Thun-Hohenstein, L., Trebaticka, J., van West, D., Vitiello, B., Young, H., Yurteri, N., Zepf, F.D., Zielinska-Wieniawska, A., and Zuddas, A.
- Subjects
Telepsychiatry ,Adolescent ,Adolescent Psychiatry ,COVID-19 ,Child ,Humans ,Pandemics ,Psychiatry ,Surveys and Questionnaires ,Telemedicine/methods ,United Nations ,Child and adolescent psychiatry ,Europe ,05 social sciences ,Medizin ,Original Contribution ,General Medicine ,030227 psychiatry ,03 medical and health sciences ,Psychiatry and Mental health ,0302 clinical medicine ,Pediatrics, Perinatology and Child Health ,Developmental and Educational Psychology ,0501 psychology and cognitive sciences ,Pediatrics, Perinatology, and Child Health ,050104 developmental & child psychology - Abstract
In April 2020, the European Society for Child and Adolescent Psychiatry (ESCAP) Research Academy and the ESCAP Board launched the first of three scheduled surveys to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on child and adolescent psychiatry (CAP) services in Europe and to assess the abilities of CAP centers to meet the new challenges brought on by the crisis. The survey was a self-report questionnaire, using a multistage process, which was sent to 168 heads of academic CAP services in 24 European countries. Eighty-two responses (56 complete) from 20 countries, representing the subjective judgement of heads of CAP centers, were received between mid-April and mid-May 2020. Most respondents judged the impact of the crisis on the mental health of their patients as medium (52%) or strong (33%). A large majority of CAP services reported no COVID-19 positive cases among their inpatients and most respondents declared no or limited sick leaves in their team due to COVID-19. Outpatient, daycare, and inpatient units experienced closures or reductions in the number of treated patients throughout Europe. In addition, a lower referral rate was observed in most countries. Respondents considered that they were well equipped to handle COVID-19 patients despite a lack of protective equipment. Telemedicine was adopted by almost every team despite its sparse use prior to the crisis. Overall, these first results were surprisingly homogeneous, showing a substantially reduced patient load and a moderate effect of the COVID-19 crisis on psychopathology. The effect on the organization of CAP services appears profound. COVID-19 crisis has accelerated the adoption of new technologies, including telepsychiatry. Supplementary Information The online version contains supplementary material available at 10.1007/s00787-020-01699-x.
- Published
- 2022
31. Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa
- Author
-
Dirk Van West, Palmiero Monteleone, Simon Scharpé, Filip Goossens, Eugene Bosmans, Michael Maes, Mario Maj, R. Bencivenga, Clinical and Lifespan Psychology, Maes, M, Monteleone, P, Bencivenga, R, Goossens, F, Maj, Mario, VAN WEST, D, Bosmans, E, and Scharpe, S.
- Subjects
Adult ,medicine.medical_specialty ,Anorexia Nervosa ,Endocrinology, Diabetes and Metabolism ,education ,Fluorescence spectrometry ,Anorexia ,behavioral disciplines and activities ,Body Mass Index ,Endocrinology ,Prolyl endopeptidase ,Internal medicine ,mental disorders ,medicine ,Humans ,Bulimia ,Biological Psychiatry ,Endocrine and Autonomic Systems ,Bulimia nervosa ,Body Weight ,Neuropeptides ,Serine Endopeptidases ,Fasting ,medicine.disease ,Eating Disorder Inventory ,Psychiatry and Mental health ,Eating disorders ,Spectrometry, Fluorescence ,Anorexia nervosa (differential diagnoses) ,cardiovascular system ,Regression Analysis ,Female ,Seasons ,medicine.symptom ,Psychology ,Prolyl Oligopeptidases ,Body mass index ,circulatory and respiratory physiology ,medicine.drug - Abstract
The aim of this study was to examine whether anorexia and bulimia nervosa are accompanied by lower serum activity of prolyl endopeptidase (PEP;EC 3.4.21.26; post-proline cleaving enzyme), a cytosolic endopeptidase which cleaves peptide bonds on the carboxyl side of proline in proteins of relatively small molecular mass. Substrates of PEP are, amongst others, neuroactive peptides, such as arginine vasopressin, luteinizing hormone-releasing hormone, thyrotropin releasing hormone,alpha-melanocyte secreting hormone, substance P, oxytocin, bradykinin, neurotensin and angiotensin (Ag) I and II. Serum PEP activity was measured in the serum of 18 normal women, 21 anorexia nervosa and 21 bulimia nervosa women by means of a fluoremetric method. The Bulimic Investigatory Test, Edinburgh (BITE), the Eating Disorder Inventory (EDI) and the Hamilton Depression Rating Scale (HDRS) were scored. Serum PEP activity was significantly lower in patients with bulimia nervosa and anorexia nervosa, irrespective of the restricted or binging subtype, than in normal controls. There were significant and inverse correlations between serum PEP activity and the HDRS and BITE. In anorectic patients, but not in normal or bulimic patients, there was a significant correlation between serum PEP and body mass index. In bulimic patients, but not in normal or anorectic patients, there was a significant correlation between serum PEP and duration of illness. It is concluded that lowered serum PEP activity takes part in the pathophysiology of anorexia and bulimia nervosa. It is hypothesized that a combined dysregulation of PEP and neuroactive peptides, which are substrates of PEP, could be an integral component of eating disorders.
- Published
- 2001
32. Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa
- Author
-
I. De Meester, Simon Scharpé, D. van West, A. Lin, Christine Durinx, Marie-Berthe Maes, A. Di Lieto, Mario Maj, Palmiero Monteleone, VAN WEST, D, Monteleone, P, DI LIETO, A, DE MEESTER, I, Durinx, C, Scharpe, S, Lin, A, Maj, Mario, Maes, M., and Clinical and Lifespan Psychology
- Subjects
Adult ,medicine.medical_specialty ,animal structures ,Dipeptidyl Peptidase 4 ,Anorexia ,behavioral disciplines and activities ,Severity of Illness Index ,Dipeptidyl peptidase ,Body Mass Index ,Internal medicine ,Surveys and Questionnaires ,mental disorders ,medicine ,Humans ,Pharmacology (medical) ,Bulimia ,Biological Psychiatry ,Dipeptidyl peptidase-4 ,Psychiatric Status Rating Scales ,Bulimia nervosa ,Body Weight ,General Medicine ,Neuropeptide Y receptor ,medicine.disease ,Eating Disorder Inventory ,Psychiatry and Mental health ,Eating disorders ,Endocrinology ,Female ,medicine.symptom ,Psychology ,Body mass index - Abstract
The aim of this study was to examine whether anorexia nervosa and bulimia nervosa are accompanied by lower serum activity of dipeptidyl peptidase IV (DPP IV, EC 3.4.14.5), a membrane-bound serine protease that catalyses the cleavage of dipeptides from the amino-terminus of oligo- and polypeptides. Substrates of DPP IV are, amongst others, neuroactive eptides, such as substance P, growth hormone releasing hormone, neuropeptide Y, and peptide YY. DPP IV activity was measured in the serum of 21 women with anorexia nervosa, 21 women with bulimia nervosa and 18 normal women. Serum ¶DPP IV activity was significantly lower in patients with anorexia nervosa and bulimia nervosa than in the normal controls. In the total study group, there were significant and inverse relationships between serum DPP IV activity and the total scores on the Bulimic Investigatory Test, Edinburgh, the Eating Disorder Inventory (EDI) and the Hamilton Depression Rating Scale. In the total study group no significant correlations between DPP IV and age, body weight or body mass index could be found. It is concluded that lowered serum DPP IV activity takes part in the pathophysiology of anorexia and bulimia nervosa. It is hypothesised that a combined dysregulation of DPP IV and neuroactive peptides, which are substrates of DPP IV, e.g. neuropeptide Y and peptide YY, could be an integral component of eating disorders.
- Published
- 2000
33. [Profiling patients with early onset psychosis in Flanders].
- Author
-
Heirbaut N, Dhar M, and Van West D
- Subjects
- Adult, Child, Adolescent, Humans, Hospitalization, Risk Factors, Parents, Psychotic Disorders diagnosis
- Abstract
Background: Little is known about patients with early onset psychosis (EOP) because of the low prevalence and separation of mental health care for adolescents and adults., Aim: To describe characteristics of patients with EOP, their global functioning and their journey concerning healthcare, education, employment status, living situation and wellbeing in the years following onset of psychosis., Method: Data about demography, symptoms, treatment and functioning were collected from electronic patient records for 31 patients with EOP. Fourteen of these patients completed a questionnaire after discharge from inpatient treatment in ZNA University Child and Youth Psychiatry in Antwerp (UKJA) regarding after care, education, work and living conditions and wellbeing., Results: Most patients developed severe psychotic symptoms before the age of 16 that required prolonged intensive psychiatric treatment. They showed multiple risk factors associated with psychosis. Following inpatient treatment most patients received special needs education and a majority transitioned into adult psychiatric care. Parents were the main source of social support for patients., Conclusion: During recovery access to support in different domains of life is needed. If we want to offer adequate care for each patient the organization of mental healthcare and assistance needs to be improved.
- Published
- 2023
34. [What are possible applications of virtual reality for forensic psychiatry?]
- Author
-
Roggeman S, Van Wallendael KLP, Van West D, and Jeandarme I
- Subjects
- Aggression, Forensic Psychiatry, Humans, Psychotherapy, Virtual Reality, Virtual Reality Exposure Therapy
- Abstract
Background: Virtual reality (VR) has been on the rise in recent years due to the better quality and accessibility of VR glasses and software. Despite the fact that VR is being used more often in psychiatric care, little is known about the possible applications of VR in forensic psychiatry., Aim: To investigate which possible VR-applications already exist that can also be used in forensic psychiatry and what the possible risks are., Method: Scientific literature was consulted in PubMed, Web of Knowledge, Embase en Cochrane Library to search for immersive VR-applications for aggression, motivation and the most prevalent psychopathologies in forensic psychiatry., Results: Several relevant VR-applications were found that can be used in the diagnosis or treatment of forensic psychiatric patients. Despite the limited number of empirical studies, several authors emphasize the potential benefits of VR for this target group., Conclusion: Due to the low number of studies of good quality on the use of VR in psychiatric care, it is currently not yet possible to draw clear conclusions about efficiency, deployability and specific applications. However, there is enough potential within forensic psychiatry to integrate VR into various parts of the care process, such as treatment, diagnosis and risk assessment.
- Published
- 2021
35. Towards a definition of multiple and complex needs in children and youth: Delphi study in Flanders and international survey.
- Author
-
Van den Steene H, van West D, and Glazemakers I
- Abstract
Background: Multiple and complex needs (MCN) in children and youth jeopardize their development and pose significant challenges to the different professionals they meet. However, there is no agreed-upon definition of this vulnerable population., Objectives: To develop a definition of 'MCN in children and youth' that is meaningful for all professionals involved in care delivery for this population., Method: A cross-sector, multidisciplinary, and geographically spread panel of 47 experts representing mental health, youth care, juvenile justice, and education in Flanders participated in an online Delphi study. Qualitative analysis of answers in the first round yielded four definition possibilities that participants then ranked in the second round. In the last round, participants rated their agreement with the highest ranked definition. An additional survey asked 25 international experts to rate and comment their agreement with the final definition., Results: The final definition was: Children and adolescents with profound and interacting needs in the context of issues on several life domains (family context, functioning and integration in society) as well as psychiatric problems. The extent of their needs exceeds the capacity (expertise and resources) of existing services and sequential interventions lead to discontinuous care delivery. As such, existing services do not adequately meet the needs of these youths and their families. Cross-sector, integrated and assertive care delivery is necessary for safeguarding the wellbeing, development and societal integration of these young people. Response rates to the three Delphi rounds were 76.6, 89.1, and 91.3%. The definition was widely endorsed among Flemish (93.2% agreement) and international experts (88% agreement)., Conclusion: A definition of MCN in children and youth was constructed using the Delphi method and further evaluated for international relevance in an additional survey. Such an agreed-upon definition can be valuable for optimizing care delivery and conducting research.
- Published
- 2019
- Full Text
- View/download PDF
36. [Potential of participatory action research for clients, professionals and researchers in mental healthcare].
- Author
-
Van den Steene H, Van West D, and Glazemakers I
- Subjects
- Health Services Research, Humans, Mental Health, Research Personnel, Community Mental Health Services organization & administration, Community-Based Participatory Research organization & administration, Psychiatry organization & administration, Psychiatry standards
- Abstract
Background: In participatory action research (par), researchers, practitioners and the community engage in a research process together. This research approach has the potential to assist in bridging the research-practice gap by starting from practice needs and using joint expertise and experiences to enrich scientific knowledge, optimise clinical practice and empower stakeholders from different backgrounds.
AIM: To discuss the potential benefits of par for clients, professionals and researchers in the field of mental healthcare.
METHOD: Starting from the literature on par, fundamental characteristics and benefits of this research approach in the field of mental healthcare are described and illustrated with an example from practice.
RESULTS: par in mental healthcare can contribute to enriching prepositional and practical knowledge, facilitate positive social change in care delivery, empower all stakeholders, and ultimately make a significant contribution to the integration of research and practice.
CONCLUSION: par is valuable for clients, professionals and researchers in a variety of projects in mental healthcare.- Published
- 2019
37. Professionals' views on the development process of a structural collaboration between child and adolescent psychiatry and child welfare: an exploration through the lens of the life cycle model.
- Author
-
Van den Steene H, van West D, Peeraer G, and Glazemakers I
- Subjects
- Adolescent, Child, Female, Focus Groups, Health Services Research, Humans, Life Cycle Stages, Adolescent Psychiatry, Child Welfare, Cooperative Behavior, Mental Health
- Abstract
This study, as a part of a participatory action research project, reports the development process of an innovative collaboration between child and adolescent psychiatry and child welfare, for adolescent girls with multiple and complex needs. The findings emerge from a qualitative descriptive analysis of four focus groups with 30 professionals closely involved in this project, and describe the evolution of the collaborative efforts and outcomes through time. Participants describe large investments and negative consequences of rapid organizational change in the beginning of the collaboration project, while benefits of the intensive collaboration only appeared later. A shared person-centred vision and enhanced professionals' confidence were pointed out as important contributors in the evolution of the collaboration. Findings were compared to the literature and showed significant analogy with the life cycle model for shared service centres that describe the maturation of collaborations from a management perspective. These findings enrich the knowledge about the development process of collaboration in health and social care. In increasingly collaborative services, child and adolescent psychiatrists and policy makers should be aware that gains from a collaboration will possibly only be achieved in the longer term, and benefit from knowing which factors have an influence on the evolution of a collaboration project.
- Published
- 2018
- Full Text
- View/download PDF
38. Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial.
- Author
-
Verlaet AA, Ceulemans B, Verhelst H, Van West D, De Bruyne T, Pieters L, Savelkoul HF, and Hermans N
- Subjects
- Adjuvants, Immunologic adverse effects, Antioxidants adverse effects, Attention Deficit Disorder with Hyperactivity immunology, Attention Deficit Disorder with Hyperactivity metabolism, Attention Deficit Disorder with Hyperactivity psychology, Belgium, Biomarkers blood, Biomarkers urine, Central Nervous System Stimulants adverse effects, Child, Clinical Protocols, Cytokines blood, Double-Blind Method, Face microbiology, Feeding Behavior, Female, Flavonoids adverse effects, Humans, Male, Methylphenidate adverse effects, Oxidative Stress drug effects, Plant Extracts, Research Design, Surveys and Questionnaires, Time Factors, Treatment Outcome, Adjuvants, Immunologic therapeutic use, Antioxidants therapeutic use, Attention Deficit Disorder with Hyperactivity drug therapy, Central Nervous System Stimulants therapeutic use, Child Behavior drug effects, Flavonoids therapeutic use, Methylphenidate therapeutic use
- Abstract
Background: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity disorder (ADHD), is associated with serious adverse effects like arrhythmia. Evidence on the association of ADHD with immune and oxidant-antioxidant imbalances offers potential for antioxidant and/or immunomodulatory nutritional supplements as ADHD therapy. One small randomised trial in ADHD suggests, despite various limitations, therapeutic benefit from Pycnogenol®, a herbal, polyphenol-rich extract., Methods: This phase III trial is a 10-week, randomised, double-blind, placebo and active treatment controlled multicentre trial with three parallel treatment arms to compare the effect of Pycnogenol® to MPH and placebo on the behaviour of 144 paediatric ADHD and attention-deficit disorder (ADD) patients. Evaluations of behaviour (measured by the ADHD-Rating Scale (primary endpoint) and the Social-emotional Questionnaire (SEQ)), immunity (plasma cytokine and antibody levels, white blood cell counts and faecal microbial composition), oxidative stress (erythrocyte glutathione, plasma lipid-soluble vitamins and malondialdehyde and urinary 8-OHdG levels, as well as antioxidant enzyme activity and gene expression), serum zinc and neuropeptide Y level, urinary catecholamines and physical complaints (Physical Complaints Questionnaire) will be performed in week 10 and compared to baseline. Acceptability evaluations will be based on adherence, dropouts and reports of adverse events. Dietary habits will be taken into account., Discussion: This trial takes into account comorbid behavioural and physical symptoms, as well as a broad range of innovative immune and oxidative biomarkers, expected to provide fundamental knowledge on ADHD aetiology and therapy. Research on microbiota in ADHD is novel. Moreover, the active control arm is rather unseen in research on nutritional supplements, but of great importance, as patients and parents are often concerned with the side effects of MPH., Trial Registration: Clinicaltrials.gov number: NCT02700685 . Registered on 18 January 2016. EudraCT 2016-000215-32 . Registered on 4 October 2016.
- Published
- 2017
- Full Text
- View/download PDF
39. [Prevalence of the use of psychoactive medication to treat young persons with autism spectrum disorder in the province of Antwerp, Belgium].
- Author
-
Heyde E, Dhar M, Hellemans H, Schoentjes E, and Van West D
- Subjects
- Adolescent, Belgium, Child, Child, Preschool, Female, Humans, Infant, Male, Prevalence, Surveys and Questionnaires, Treatment Outcome, Antipsychotic Agents therapeutic use, Autism Spectrum Disorder drug therapy, Complementary Therapies, Drug Utilization statistics & numerical data
- Abstract
Background: Very little information is available concerning the prevalence of the use of medication for treatment of individuals with autism spectrum disorder (ASD), particularly in European countries. Earlier studies have shown that a large number of patients with ASD use at least one psychoactive drug and that the numbers are increasing. Even in the nineties, studies suggested that the frequent use of psychoactive medication was widespread, although at the time there were only limited grounds for this assumption., Aim: To assess the prevalence with which psychoactive medication and complementary and alternative medicine (CAM) are being used for treating young people with ASD, and also to investigate relations between medication use and a number of individual characteristics that are included in the Behavioral Model of Health Service Use., Method: The study sample (0-17 years) in the province of Antwerp, Belgium, was recruited by various means. We used a questionnaire that had been previously used in North American studies and that had to be completed by the parents of the young persons involved in the study., Results: We included data from 263 questionnaires. In our sample 42.6% of the young persons used one or more one psychoactive drug. More than 12.2% used more than one drug. The most frequently used psychoactive drugs were ADHD-medication (31.6%) and antipsychotics (16.7%). About 14% used at least one CAM. We found a positive relationship between the use of medication and psychiatric comorbidity and/or epilepsy, the severity of autism and the parents' living conditions., Conclusion: We found a relatively low use of antipsychotics, antidepressants, mood stabilisers and sedatives, the prevalence being lower that that reported in North American studies. Our findings appear to be in accordance with current clinical guidelines.
- Published
- 2016
40. [Case report: The child- and adolescent psychiatric phenotype of a brother and sister with 16p11.2 microduplication].
- Author
-
Afschrift HC, van den Steene HC, Dhar M, and Van West D
- Subjects
- Adolescent, Chromosomes, Human, Pair 16 genetics, Female, Humans, Male, Phenotype, Segmental Duplications, Genomic, Abnormalities, Multiple genetics, Attention Deficit Disorder with Hyperactivity genetics, Developmental Disabilities genetics
- Abstract
16p11.2 microduplication is linked with a vulnerability for a range of psychiatric and somatic problems, with variable expression and penetration rate. We discuss the phenotypical expression of this microduplication with the case of a brother and sister. Both subjects went through child psychiatric diagnostics and treatment, where a varying degree of developmental delay and symptoms that match an attention deficit/hyperactivity disorder were observed in combination with short stature and low body mass index.
- Published
- 2016
41. [Risk factors and development course of conduct disorder in girls; a review].
- Author
-
Merckx W and Van West D
- Subjects
- Adolescent, Antisocial Personality Disorder epidemiology, Child, Female, Humans, Personality Inventory, Psychometrics, Risk Factors, Age of Onset, Conduct Disorder epidemiology, Personality Development
- Abstract
Background: So far there have been relatively few studies of conduct disorder in girls. It is very important that professionals engaged in preventing and treating this disorder have a sound knowledge of the risk factors involved and of the developmental course of the disorder., Aim: To provide an overview of what is known about the risk factors and about the way in which conduct disorder develops in girls., Method: We searched the Eric, PubMed and Medline databases for articles on conduct disorder in girls. We reviewed 41 studies and we summarised the results., Results: Several risk factors contribute to the development of conduct disorder in girls. Just like boys, girls too can display the life-course-persistent pathway of antisocial behavior. Such girls are often associated with serious risk factors. Those with serious forms of antisocial behaviour have an increased risk of experiencing adjustment problems in later life., Conclusion: Future research in this area will have to concentrate on the creation of adequate prevention and treatment programs.
- Published
- 2016
42. Motor impairment among different psychiatric disorders: Can patterns be identified?
- Author
-
Van Damme T, Fransen E, Simons J, van West D, and Sabbe B
- Subjects
- Adolescent, Aptitude, Child, Diagnosis, Differential, Humans, Linear Models, Male, Neuropsychological Tests, Reference Values, Mental Disorders diagnosis, Mental Disorders psychology, Motor Skills, Psychomotor Disorders diagnosis, Psychomotor Disorders psychology
- Abstract
The aim of this study was to explore motor impairment in male adolescents suffering from psychiatric conditions. Taking into account the heterogeneity of a clinical population, motor profiles of distinctive diagnostic groups were evaluated. Whether or not motor ability discriminates between several diagnostic categories was investigated. The Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2) was administered to examine a detailed motor profile. The motor abilities of a clinical population (n=144) were compared to those of typically developing peers (n=87), using independent t-tests. To account for differences in intellectual functioning, a one-way ANCOVA was performed. To investigate the extent to which a specific diagnosis contributes to variation in motor scores a stepwise linear regression approach was applied. Results indicated that the clinical group performed significantly worse in comparison to the control group on all BOT-2 scales, even after controlling for IQ. The constructed models indicated that diagnostic categories accounted for a significant amount of the variance in motor ability scores. The results imply that motor ability of adolescents with a psychiatric disorder is in need of attention, regardless of the diagnosis and support the notion that objective motor assessment should be part of routine clinical practice., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
43. Motor abilities of children and adolescents with a psychiatric condition: A systematic literature review.
- Author
-
Damme TV, Simons J, Sabbe B, and van West D
- Abstract
Aim: To summarize research regarding the motor abilities of children and adolescents who suffer from a common psychiatric condition., Methods: In order to outline the current knowledge regarding the motor abilities of children and adolescents with autism spectrum disorders (ASD), attention deficit hyperactivity disorder (ADHD), disruptive behavior disorders (DBD) and depression, a comprehensive systematic literature search was carried out using PubMed, Medline and ERIC databases. The databases were searched for relevant English language articles published between January 1990 and April 2014. Only studies that conducted a quantitative evaluation of motor ability and concerned individuals aged 0-18 years were included. A separate search was conducted for each disorder (ASD, ADHD, DBD, depression) in conjunction with each of the following keywords: (psycho/perceptuo) motor/movement skill(s), (psycho/perceptuo) motor/movement abilities, (psycho/perceptuo) motor/movement impairment, (psycho/perceptuo) motor/movement problem(s), motor function, motor coordination, motor performance, motor deficit(s). To detect supplementary relevant literature, the reference lists of the retrieved articles were examined., Results: The search strategy yielded 51 studies meeting the inclusion criteria. In total, 28 studies were included that examined the motor abilities of children and adolescents with ASD. All studies indicated that they performed below average on various standardized motor assessment instruments. The overall prevalence rate for impairment in motor abilities ranged from 33% to 100%. Twenty-seven studies examined the motor abilities of children and adolescents with ADHD. Depending on the type of motor assessment tool and the cut-off points used by different researchers, prevalence rates of impairment in motor abilities are highly variable and ranged from 8% to 73%. Remarkably, there is a paucity of research addressing the motor abilities of individuals with DBD or depression. Furthermore, methodological problems, such as measurement and comorbidity issues, complicate the generalization of the findings., Conclusion: Research suggests that motor impairment is highly prevalent in some psychiatric conditions, particularly ASD and ADHD. However, future work is necessary to draw sound conclusions.
- Published
- 2015
- Full Text
- View/download PDF
44. Motor abilities of adolescents with a disruptive behavior disorder: The role of comorbidity with ADHD.
- Author
-
Van Damme T, Sabbe B, van West D, and Simons J
- Subjects
- Adolescent, Attention Deficit and Disruptive Behavior Disorders epidemiology, Case-Control Studies, Child, Comorbidity, Humans, Male, Motor Skills, Attention Deficit Disorder with Hyperactivity epidemiology, Conduct Disorder epidemiology, Motor Skills Disorders epidemiology
- Abstract
The aim of this study was to explore the incidence, type and severity of motor impairment in male adolescents with a disruptive behavior disorder (DBD) and evaluate the role of comorbid ADHD. The Bruininks-Oseretsky test of motor proficiency, Second Edition was administered to examine a detailed motor profile and to compare the motor abilities of individuals with DBD (n = 99) to those of controls (n = 87). Additional subgroup analyses were conducted within the clinical population and encompassed (1) analyzing differences in motor profiles between individuals diagnosed with oppositional defiant disorder (ODD) or conduct disorder (CD) and (2) comparing the motor profiles of individuals with or without comorbid ADHD. The results indicated that individuals with a DBD showed a mixed motor impairment profile. Even after controlling for IQ, the DBD group obtained significantly lower scores in comparison to controls. The ODD and CD subgroups showed a similar motor profile. Presence of comorbid ADHD did not produce major differences in the motor profile. As approximately 79% of the adolescents with a DBD suffered from motor impairment, motor ability needs to be adequately addressed in research as well as in clinical practice., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
45. [Early-onset eating disorders: a review of the literature].
- Author
-
Poppe I, Simons A, Glazemakers I, and Van West D
- Subjects
- Adolescent, Age of Onset, Anorexia Nervosa prevention & control, Anorexia Nervosa psychology, Child, Humans, Netherlands epidemiology, Risk Factors, Anorexia Nervosa diagnosis, Anorexia Nervosa epidemiology
- Abstract
Background: The incidence of anorexia nervosa (AN) in adolescents has increased significantly in recent years. In several studies and in the media it has been suggested that AN has recently become more prevalent in the pre-adolescence. In view of the impact that an eating disorder can have on a child, it is important to diagnose and start treating the illness as early as possible., Aim: To review the literature on the characteristics and susceptibilities of patients with eating disorders because this information can be important for early diagnosis, prevention and identification of susceptibilities to early-onset eating disorders., Method: We searched the literature for articles relating to early-onset eating disorders. We based our search on PubMed and on related relevant articles listed in the references. We selected 34 relevant articles published between 1987 and 2014., Results: The literature lists characteristics and susceptibilities at various levels. Many types of factors are involved; examples of 'biological' factors are prior streptococcal infection, previous consultations with GP and a patients medical history; psychological factors include comorbidity, temperament, a particular personality profile, maturation-anxiety; environmental factors such as family history, family functioning and/or stressful events can play a role in the development of eating disorders. CONCLUSION The literature indicates that the early development of AN in children is related to a complex combination of etiological factors. However, there is a need for more research into this group of patients.
- Published
- 2015
46. [Child and adolescent psychiatry: inspiring and dynamic].
- Author
-
Reichart CG, Roza S, van Amelsvoort TA, and Van West D
- Subjects
- Adolescent, Adolescent Psychiatry trends, Child, Female, Humans, Male, Netherlands, Transition to Adult Care, Child Psychiatry trends
- Published
- 2015
47. [Reform of the Belgian mental health care system for children and adolescents].
- Author
-
Van West D and van Grootel L
- Subjects
- Adolescent, Belgium, Child, Health Policy, Humans, Mental Health Services trends, National Health Programs, Health Care Reform organization & administration, Mental Health Services organization & administration
- Abstract
Background: The Belgian child and adolescent mental health care system is in the process of being substantially reformed and re-shaped., Aim: To outline recent reforms in Belgian child and adolescent mental health care., Method: To provide an overview of the recent literature on service delivery and on the organisation of the Belgian mental health care system for children and adolescents., Results: On the basis of various studies a National Plan for Child and Adolescent Mental Health was drawn up and recently approved., Conclusion: According to this National Plan additional measures will be taken to help children and young people with mental health problems. Networking will play an increasingly important role in the new organisational configuration of the new mental health policy.
- Published
- 2015
48. [Hallucinations and obsessive behaviour in an infant with autism spectrum disorder: diagnostic problems].
- Author
-
Devriese J, Dhar M, Walleghem D, and van West D
- Subjects
- Child, Comorbidity, Diagnosis, Differential, Female, Humans, Obsessive-Compulsive Disorder drug therapy, Selective Serotonin Reuptake Inhibitors therapeutic use, Autism Spectrum Disorder diagnosis, Hallucinations diagnosis, Obsessive-Compulsive Disorder diagnosis, Psychotic Disorders diagnosis
- Abstract
Regular non-medical treatment of a 6-year-old female patient with autism spectrum disorder failed due to comorbid compulsions and hallucinations. Differential diagnosis included obsessive-compulsive disorder and psychosis. The patient's young age complicated accurate diagnosis and management. In this case we opted for a diagnostic follow-up, resulting in treatment with a selective serotonin reuptake inhibitor because of the patient's frequent compulsions. This reduced the symptoms significantly.
- Published
- 2015
49. [Measuring client satisfaction in youth mental health care: qualitative methods and satisfaction questionnaires].
- Author
-
Vanderfaeillie J, Stroobants T, van West D, and Andries C
- Subjects
- Adolescent, Adolescent Health Services standards, Child, Child, Preschool, Female, Humans, Male, Personal Satisfaction, Psychometrics, Surveys and Questionnaires, Child Health Services standards, Mental Health Services standards, Patient Satisfaction, Patients psychology
- Abstract
Background: Quality youth care and decisions about youth care should ideally be based on a combination of empirical data, the clinical judgment of health professionals and the views and preferences of clients. Additionally, the treatment provided needs to fit in with the client's social and cultural background. Clients' views about their treatment are often collected via satisfaction measurements and particularly via satisfaction questionnaires., Aim: To make a critical analysis of the factors that determine both client satisfaction and the content of the satisfaction questionnaires used as a measurement method in youth care., Method: We made a selective study of the relevant literature., Results: Our results show that client satisfaction is not an indicator of the effectiveness of treatment and that the degree of client satisfaction varies according to the client's outlook and perspective. Apparently, there are many disadvantages of using questionnaires as a measurement method., Conclusion: For the collection of a young person's views, qualitative methods seem to be more effective than questionnaires.
- Published
- 2015
50. Long-term follow-up on the effect of combined therapy of bile acids and statins in the treatment of cerebrotendinous xanthomatosis: a case report.
- Author
-
Luyckx E, Eyskens F, Simons A, Beckx K, Van West D, and Dhar M
- Subjects
- Adult, Atorvastatin, Cognition drug effects, Drug Therapy, Combination, Follow-Up Studies, Heptanoic Acids therapeutic use, Humans, Male, Neuropsychological Tests, Pyridines therapeutic use, Pyrroles therapeutic use, Simvastatin therapeutic use, Treatment Outcome, Xanthomatosis, Cerebrotendinous psychology, Chenodeoxycholic Acid therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Xanthomatosis, Cerebrotendinous drug therapy
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.